Dysregulation of FcRn has been reported to exert effects on the prognosis of non-small cell lung cancer, colorectal cancer, and hepatocellular carcinoma (Dalloneau et al., 2016; Shi et al., 2016). Here, FCGRT is linked to non-small cell lung carcinoma.